Clinical trial
Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD…
NCT00144339 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00144339 |
|---|---|
| Title | Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients |
| Official title | A Randomized, Double-blind, Placebo-controlled, Parallel Group Trial Assessing the Rate of Decline of Lung Function With Tiotropium 18 mcg Inhalation Capsule Once Daily in Patients With Chronic Obstructive Pulmonary Disease (COPD). |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | tiotropium, placebo |
| Enrollment | 5,993 |
| Start date | Dec 1, 2002 |
| Primary completion | Feb 1, 2008 |
| First posted | Sep 5, 2005 |
| Last update posted | May 20, 2014 |
| Countries | Argentina, Australia, Austria, Belgium, Brazil, Czechia, Denmark, Finland, France, Germany, Greece, Hong Kong and 25 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: